nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CHAT—autonomic nervous system—Gilles de la Tourette syndrome	0.0776	0.15	CbGeAlD
Nicotine—CHAT—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0686	0.142	CbGpPWpGaD
Nicotine—CHRNA4—autonomic nervous system—Gilles de la Tourette syndrome	0.0335	0.0647	CbGeAlD
Nicotine—MAOA—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.0254	0.0527	CbGpPWpGaD
Nicotine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0233	0.0484	CbGpPWpGaD
Nicotine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0226	0.0469	CbGpPWpGaD
Nicotine—CHRNA5—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0211	0.0437	CbGpPWpGaD
Nicotine—MAOA—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.0202	0.0418	CbGpPWpGaD
Nicotine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0177	0.0367	CbGpPWpGaD
Nicotine—CHRNB3—midbrain—Gilles de la Tourette syndrome	0.0172	0.0333	CbGeAlD
Nicotine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0171	0.0356	CbGpPWpGaD
Nicotine—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.016	0.0331	CbGpPWpGaD
Nicotine—CHRNA5—nervous system—Gilles de la Tourette syndrome	0.0156	0.0301	CbGeAlD
Nicotine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0156	0.0323	CbGpPWpGaD
Nicotine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0151	0.0313	CbGpPWpGaD
Nicotine—CHRNA5—central nervous system—Gilles de la Tourette syndrome	0.015	0.029	CbGeAlD
Nicotine—CHRNA6—midbrain—Gilles de la Tourette syndrome	0.0144	0.0278	CbGeAlD
Nicotine—CHRNB3—nervous system—Gilles de la Tourette syndrome	0.0142	0.0273	CbGeAlD
Nicotine—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0141	0.0292	CbGpPWpGaD
Nicotine—CHRNB3—central nervous system—Gilles de la Tourette syndrome	0.0136	0.0263	CbGeAlD
Nicotine—CHAT—midbrain—Gilles de la Tourette syndrome	0.0119	0.023	CbGeAlD
Nicotine—CHRNA5—brain—Gilles de la Tourette syndrome	0.0119	0.023	CbGeAlD
Nicotine—CHRNA6—nervous system—Gilles de la Tourette syndrome	0.0118	0.0228	CbGeAlD
Nicotine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.0116	0.0241	CbGpPWpGaD
Nicotine—CHRNA6—central nervous system—Gilles de la Tourette syndrome	0.0114	0.022	CbGeAlD
Nicotine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0112	0.0232	CbGpPWpGaD
Nicotine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.0109	0.0226	CbGpPWpGaD
Nicotine—CHRNB3—brain—Gilles de la Tourette syndrome	0.0108	0.0209	CbGeAlD
Nicotine—CHRNB4—nervous system—Gilles de la Tourette syndrome	0.0107	0.0207	CbGeAlD
Nicotine—CHRNB4—central nervous system—Gilles de la Tourette syndrome	0.0103	0.0199	CbGeAlD
Nicotine—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.0101	0.021	CbGpPWpGaD
Nicotine—CHAT—nervous system—Gilles de la Tourette syndrome	0.00982	0.0189	CbGeAlD
Nicotine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00981	0.0203	CbGpPWpGaD
Nicotine—CHAT—central nervous system—Gilles de la Tourette syndrome	0.00945	0.0182	CbGeAlD
Nicotine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00914	0.019	CbGpPWpGaD
Nicotine—CHRNA6—brain—Gilles de la Tourette syndrome	0.00903	0.0174	CbGeAlD
Nicotine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00866	0.018	CbGpPWpGaD
Nicotine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00841	0.0174	CbGpPWpGaD
Nicotine—CHRNB2—midbrain—Gilles de la Tourette syndrome	0.00826	0.0159	CbGeAlD
Nicotine—CHRNB4—brain—Gilles de la Tourette syndrome	0.0082	0.0158	CbGeAlD
Nicotine—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.00783	0.0163	CbGpPWpGaD
Nicotine—CHAT—brain—Gilles de la Tourette syndrome	0.0075	0.0145	CbGeAlD
Nicotine—CHRNB2—nervous system—Gilles de la Tourette syndrome	0.00679	0.0131	CbGeAlD
Nicotine—CHRNA3—nervous system—Gilles de la Tourette syndrome	0.00658	0.0127	CbGeAlD
Nicotine—CHRNB2—central nervous system—Gilles de la Tourette syndrome	0.00654	0.0126	CbGeAlD
Nicotine—CHRNA3—central nervous system—Gilles de la Tourette syndrome	0.00634	0.0122	CbGeAlD
Nicotine—MAOB—Alpha-synuclein signaling—SLC6A3—Gilles de la Tourette syndrome	0.00625	0.013	CbGpPWpGaD
Nicotine—CHRNA2—nervous system—Gilles de la Tourette syndrome	0.00612	0.0118	CbGeAlD
Nicotine—CHRNA2—central nervous system—Gilles de la Tourette syndrome	0.00589	0.0114	CbGeAlD
Nicotine—CHRFAM7A—nervous system—Gilles de la Tourette syndrome	0.00532	0.0103	CbGeAlD
Nicotine—CHRNB2—brain—Gilles de la Tourette syndrome	0.00519	0.01	CbGeAlD
Nicotine—CHRNA4—midbrain—Gilles de la Tourette syndrome	0.00516	0.00996	CbGeAlD
Nicotine—CHRFAM7A—central nervous system—Gilles de la Tourette syndrome	0.00513	0.0099	CbGeAlD
Nicotine—CHRNA3—brain—Gilles de la Tourette syndrome	0.00503	0.00971	CbGeAlD
Nicotine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00491	0.0102	CbGpPWpGaD
Nicotine—CHRNA2—brain—Gilles de la Tourette syndrome	0.00468	0.00903	CbGeAlD
Nicotine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.00458	0.00949	CbGpPWpGaD
Nicotine—CHRNA7—nervous system—Gilles de la Tourette syndrome	0.0043	0.0083	CbGeAlD
Nicotine—CHRNA9—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00427	0.00885	CbGpPWpGaD
Nicotine—CHRNA4—nervous system—Gilles de la Tourette syndrome	0.00424	0.00819	CbGeAlD
Nicotine—CHRNA7—central nervous system—Gilles de la Tourette syndrome	0.00414	0.00799	CbGeAlD
Nicotine—CHRNA4—central nervous system—Gilles de la Tourette syndrome	0.00408	0.00789	CbGeAlD
Nicotine—CHRFAM7A—brain—Gilles de la Tourette syndrome	0.00407	0.00786	CbGeAlD
Nicotine—MAOB—midbrain—Gilles de la Tourette syndrome	0.00386	0.00745	CbGeAlD
Nicotine—CHRNB3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00373	0.00774	CbGpPWpGaD
Nicotine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.00359	0.00692	CbGeAlD
Nicotine—CHRNA5—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00354	0.00733	CbGpPWpGaD
Nicotine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.00345	0.00666	CbGeAlD
Nicotine—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.00343	0.00662	CbGeAlD
Nicotine—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00341	0.00707	CbGpPWpGaD
Nicotine—CYP19A1—nervous system—Gilles de la Tourette syndrome	0.00337	0.0065	CbGeAlD
Nicotine—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.0033	0.00637	CbGeAlD
Nicotine—MAOA—midbrain—Gilles de la Tourette syndrome	0.00329	0.00635	CbGeAlD
Nicotine—CHRNA7—brain—Gilles de la Tourette syndrome	0.00329	0.00635	CbGeAlD
Nicotine—CYP2A6—brain—Gilles de la Tourette syndrome	0.00328	0.00634	CbGeAlD
Nicotine—CHRNA9—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00327	0.00678	CbGpPWpGaD
Nicotine—CYP19A1—central nervous system—Gilles de la Tourette syndrome	0.00324	0.00626	CbGeAlD
Nicotine—CHRNA4—brain—Gilles de la Tourette syndrome	0.00324	0.00626	CbGeAlD
Nicotine—SLC22A1—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.00318	0.00659	CbGpPWpGaD
Nicotine—MAOB—nervous system—Gilles de la Tourette syndrome	0.00317	0.00612	CbGeAlD
Nicotine—MAOB—central nervous system—Gilles de la Tourette syndrome	0.00305	0.00589	CbGeAlD
Nicotine—SLC22A5—midbrain—Gilles de la Tourette syndrome	0.00303	0.00585	CbGeAlD
Nicotine—CHAT—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00301	0.00624	CbGpPWpGaD
Nicotine—SLC22A4—brain—Gilles de la Tourette syndrome	0.00288	0.00556	CbGeAlD
Nicotine—CHRNB3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00286	0.00593	CbGpPWpGaD
Nicotine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00282	0.00584	CbGpPWpGaD
Nicotine—SLC22A1—brain—Gilles de la Tourette syndrome	0.00274	0.00529	CbGeAlD
Nicotine—CHRNA5—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00271	0.00562	CbGpPWpGaD
Nicotine—MAOA—nervous system—Gilles de la Tourette syndrome	0.00271	0.00522	CbGeAlD
Nicotine—CHRNA6—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00268	0.00556	CbGpPWpGaD
Nicotine—SLC22A3—brain—Gilles de la Tourette syndrome	0.00262	0.00506	CbGeAlD
Nicotine—MAOA—central nervous system—Gilles de la Tourette syndrome	0.0026	0.00503	CbGeAlD
Nicotine—CYP19A1—brain—Gilles de la Tourette syndrome	0.00258	0.00497	CbGeAlD
Nicotine—CHRNB2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00255	0.0053	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00252	0.00524	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00248	0.00514	CbGpPWpGaD
Nicotine—MAOB—brain—Gilles de la Tourette syndrome	0.00242	0.00468	CbGeAlD
Nicotine—CHRNB2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00236	0.00489	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00231	0.00479	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0023	0.00478	CbGpPWpGaD
Nicotine—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00223	0.0043	CbGeAlD
Nicotine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.00216	0.00418	CbGeAlD
Nicotine—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.00214	0.00414	CbGeAlD
Nicotine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00212	0.00441	CbGpPWpGaD
Nicotine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00212	0.00439	CbGpPWpGaD
Nicotine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.00208	0.00402	CbGeAlD
Nicotine—MAOA—brain—Gilles de la Tourette syndrome	0.00207	0.00399	CbGeAlD
Nicotine—CHRNA6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00205	0.00426	CbGpPWpGaD
Nicotine—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.00203	0.00392	CbGeAlD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00198	0.00411	CbGpPWpGaD
Nicotine—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.00196	0.00377	CbGeAlD
Nicotine—SLC22A5—brain—Gilles de la Tourette syndrome	0.0019	0.00368	CbGeAlD
Nicotine—CHRNB4—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00186	0.00385	CbGpPWpGaD
Nicotine—CYP2C8—brain—Gilles de la Tourette syndrome	0.00184	0.00356	CbGeAlD
Nicotine—CHRNB2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00181	0.00375	CbGpPWpGaD
Nicotine—CYP1A1—brain—Gilles de la Tourette syndrome	0.0017	0.00329	CbGeAlD
Nicotine—CHRNA3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0017	0.00352	CbGpPWpGaD
Nicotine—CHAT—Metabolism—HDC—Gilles de la Tourette syndrome	0.00167	0.00346	CbGpPWpGaD
Nicotine—CYP2B6—brain—Gilles de la Tourette syndrome	0.00165	0.00319	CbGeAlD
Nicotine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00163	0.00315	CbGeAlD
Nicotine—CHRNA7—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00161	0.00334	CbGpPWpGaD
Nicotine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00161	0.0031	CbGeAlD
Nicotine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00157	0.00304	CbGeAlD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00156	0.00323	CbGpPWpGaD
Nicotine—CYP2E1—brain—Gilles de la Tourette syndrome	0.00155	0.003	CbGeAlD
Nicotine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00155	0.00299	CbGeAlD
Nicotine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00152	0.00314	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00142	0.00295	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—HDC—Gilles de la Tourette syndrome	0.00142	0.00294	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00135	0.00281	CbGpPWpGaD
Nicotine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00133	0.00276	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00131	0.00273	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0013	0.0027	CbGpPWpGaD
Nicotine—SLC22A4—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00128	0.00266	CbGpPWpGaD
Nicotine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00124	0.00258	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00123	0.00256	CbGpPWpGaD
Nicotine—CYP2D6—brain—Gilles de la Tourette syndrome	0.00123	0.00237	CbGeAlD
Nicotine—CHRNA2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00116	0.00241	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0011	0.00229	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00101	0.00209	CbGpPWpGaD
Nicotine—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000965	0.002	CbGpPWpGaD
Nicotine—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000962	0.002	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000883	0.00183	CbGpPWpGaD
Nicotine—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000882	0.00183	CbGpPWpGaD
Nicotine—MAOB—Metabolism—HDC—Gilles de la Tourette syndrome	0.00078	0.00162	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000747	0.00155	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000741	0.00154	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000696	0.00144	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000677	0.0014	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00066	0.00137	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00065	0.00135	CbGpPWpGaD
Nicotine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000605	0.00126	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000572	0.00119	CbGpPWpGaD
Nicotine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000564	0.00117	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000533	0.00111	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000491	0.00102	CbGpPWpGaD
Nicotine—MAOA—Metabolism—HDC—Gilles de la Tourette syndrome	0.00049	0.00102	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000489	0.00101	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000478	0.000991	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000414	0.000859	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000386	0.000801	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00038	0.000789	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000308	0.000638	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000307	0.000636	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.0003	0.000623	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000287	0.000595	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000283	0.000588	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	0.00026	0.000539	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.000232	0.000481	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000213	0.000442	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.000211	0.000438	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000181	0.000375	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000139	0.000289	CbGpPWpGaD
